China NT Pharma Group Company Limited

Exchange Code Listed Last trade Delisted
HK Main 01011  2011-04-20    
Stock code:
From
to

CCASS holding changes from 2022-03-17 to 2022-03-18

Hit the "stake change" to see the holder's history.

Some data are hidden to fit your display. Rotate?

Row CCASS ID Name Holding Change Stake
%
Stake
Δ %
Last
holding
1 B01284 HANG SENG SECURITIES LTD 44,580,500 1,356,500 2.34 0.07 2022-03-18
2 C00019 THE HONGKONG AND SHANGHAI BANKING 113,385,044 255,000 5.95 0.01 2022-03-18
3 B01668 BRIGHT SMART SECURITIES INTERNATIONAL 14,584,000 180,000 0.77 0.01 2022-03-18
4 B01955 FUTU SECURITIES INTERNATIONAL 25,931,177 125,000 1.36 0.01 2022-03-18
5 C00033 BANK OF CHINA (HONG KONG) LTD 93,926,425 100,000 4.93 0.01 2022-03-18
6 B01773 TOYO SECURITIES ASIA LTD 431,500 55,000 0.02 0.00 2022-03-18
7 B01590 INTERACTIVE BROKERS HONG KONG LTD 3,417,000 42,000 0.18 0.00 2022-03-18
8 B01224 MERRILL LYNCH FAR EAST LTD 2,001,438 13,000 0.11 0.00 2022-03-18
9 C00100 JPMORGAN CHASE BANK, NATIONAL 282,226,500 9,500 14.82 0.00 2022-03-18
10 B02192 HUAFU INTERNATIONAL SECURITIES LTD 19,500 500 0.00 0.00 2022-03-18
11 B01115 SHENWAN HONGYUAN SECURITIES (H.K.) LTD 18,527,666 -100,000 0.97 -0.01 2022-03-18
12 B01217 TAIPING SECURITIES (HK) CO LTD 805,000 -109,000 0.04 -0.01 2022-03-18
13 B01904 VALUABLE CAPITAL LTD 954,500 -247,500 0.05 -0.01 2022-03-18
14 B01130 BOCI SECURITIES LTD 47,320,000 -1,680,000 2.48 -0.09 2022-03-18
14 Total changed named holdings 648,110,250 0 34.03 0.00
229 Unchanged named holdings 1,252,270,263 0 65.75 0.00
243 Total named holdings 1,900,380,513 0 99.78 0.00
19 Unnamed Investor Participants 3,723,000 0 0.20 0.00
262 Total securities in CCASS 1,904,103,513 0 99.97 0.00
Securities not in CCASS 531,959 0 0.03 0.00
Issued securities 1,904,635,472 0 100.00 0.00 2022-02-28

Trades that settled in this date range

These data are not adjusted for splits or bonus issues during the period.

Trading date2022-03-16
Volume2,340,000
Turnover165,355
Average price0.071

Sign up for our free newsletter

Recommend Renavon to a friend

Copyright & disclaimer, Privacy policy

Back to top